Invention Publication
- Patent Title: MUTATION-INDEPENDENT GENE KNOCK-IN THERAPY TARGETING 5' UTR
-
Application No.: US17985765Application Date: 2022-11-11
-
Publication No.: US20240156985A1Publication Date: 2024-05-16
- Inventor: Wenjun Xiong , Anh Duc Hoang , Baoshan Liao
- Applicant: City University of Hong Kong
- Applicant Address: HK Kowloon
- Assignee: City University of Hong Kong
- Current Assignee: City University of Hong Kong
- Current Assignee Address: HK Kowloon
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K31/7105 ; A61K38/17 ; A61K38/46 ; A61P27/02 ; C12N9/22 ; C12N15/11 ; C12N15/86 ; C12N15/90

Abstract:
Novel 5′ untranslated region (UTR)-targeting gene knock-in (KI) compositions and methods of use are disclosed. The gene KI compositions and methods exploit homology-independent targeted integration (HITI)-mediated insertion of a wild-type coding sequence (CDS) into the 5′ UTR upstream of a translation initiation element of a mutated variant of the wild-type gene. The 5′ UTR-targeting gene KI therapy compositions and methods provide safer and more efficient gene insertion compared to other gene therapy approaches.
Information query